Navigation Links
Laser-Proton Therapy Working Group Takes Second Look at Ways to Lower Cost of Advanced Cancer Treatment

RENO, Nev. and TAHOE, Nev., Sept. 25, 2013 /PRNewswire/ -- Progress and next steps to develop lower-cost proton cancer therapy was the topic of discussion at an international initiative meeting on Friday, September 20th, 2013.

Moataz Karmalawy, Ph.D., Vice President and General Manager Worldwide Particle Therapy for Varian Medical Systems ( shared that proton therapy, in addition to its current treatment role world-wide, will likely play an even bigger role in the future of cancer therapy due to the benefit of increased accuracy and reduced side effects. 

About Proton Therapy:

Proton therapy provides advantage over traditional radiation therapy in that it deposits most of its energy at the location of a tumor. In addition to many other treatments, proton therapy shows promise for lung and liver cancers, head and neck cancers and for the treatment of children. There are still only a limited number of facilities worldwide that can perform proton therapy because of the large and specialized building requirements and overall system cost. The laser-based proton source concept may be suited for improved proton therapy both in regard to improving access through reduced system size and cost as well as through added system capability. 

About the Clinical Laser-Proton Therapy Working Group:

The group ( was founded in 2011 and is dedicated to the coordination and application of government funding, private investment, and corporate investment to evaluate viability, design a path, and develop clinical laser-based proton sources for tumor therapy.  Discussions are currently underway with potential corporate development and private investment partners.  Additional partners in the cancer research foundation and philanthropic spaces are also being sought in order to accelerate this investigation.

The group has collectively invested more than one million dollars into accelerating the assessment of this technology pathway. Some of the group members participated in obtaining a promising initial result in 2009 with the generation of 67.5 MeV laser-based protons from structured laser targets. (

Attendees or participants from the July, 2011 and September, 2013 group meetings include representation from Fox Chase Cancer Center, SCHOTT North America, Inc., National Energetics, University of Texas, Nanolabz, University of Nevada, Reno, Los Alamos National Laboratory, Kirk-Brown Consulting, Central Laser Facility, Varian Medical Systems, Logos Technologies, Imprimis Consulting, SpecTIR, LLC, and the University of Glasgow.

SOURCE Nanolabz
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chrysalis BioTherapeutics, Inc., Receives $1.5m from the National Cancer Institute to Mitigate Radiotherapy-Induced Brain Tissue Damage
2. Study Suggests that a Single Session of Stereotactic Body Radiation Therapy (Lung Radiosurgery) is a Promising Approach for Treating Inoperable Early-Stage Lung Cancer
3. Studies Show Excellent Outcomes With Strut-Based Breast Brachytherapy
4. UH Seidman Cancer Center Breaks Ground on $30 Million Proton Therapy Center
5. New Elekta Radiation Therapy Technology Takes Weeks Off of Lung Cancer Treatments
6. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
7. I-Flow Launches Patient Education Program to Build Awareness of Non-Narcotic Therapy for Post-Surgical Pain Management
8. Syndaxs Entinostat Receives Breakthrough Therapy Designation from FDA for Treatment of Advanced Breast Cancer
9. ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS
10. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
11. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy
Post Your Comments:
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Advanced Wound Care Market by Type ... Ulcers), End User (In-Patient Facility, Out-Patient Facility), and Geography ... offering. --> --> ... the description, definition and forecast of the global advanced ...
Breaking Medicine Technology:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... a safe and convenient way to dispense prescription medications at home, so he ... effective way to monitor and dispense prescription medications. In doing so, it could ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... an innovative online platform for mental health and wellness consultation, has collaborated with ... partnership will bridge the knowledge gap experienced by parents and bring advice from ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
Breaking Medicine News(10 mins):